Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of 8mg Once-daily Versus 4mg Twice-daily Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH ; 12-week, Double-blind, Randomized, Comparison, Multi-center Study

NCT01260129 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.

NCT NCT01260129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01260129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of 8mg Once-daily Versus 4mg Twice-daily Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH ; 12-week, Double-blind, Randomized, Comparison, Multi-center Study
Lead sponsor
JW Pharmaceutical
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2010
Completion date
October 31, 2011
Enrollment
424 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hypertrophy